LUXEMBOURG, November 24, 2025--(BUSINESS WIRE)--Regulatory News:
Eurofins (Paris:ERF):
Name of the Issuer | Identify code of the Issuer | Transaction day | Identify code of the financial instrument | Total daily volume (in number of shares) | Daily weighted average purchase price of the shares | Market (MIC Code) |
EUROFINS SCIENTIFIC | 529900JEHFM47DYY3S57 | 17/11/2025 | FR0014000MR3 | 20 000 | 58.7743 | XPAR |
EUROFINS SCIENTIFIC | 529900JEHFM47DYY3S57 | 18/11/2025 | FR0014000MR3 | 20 000 | 57.7048 | XPAR |
EUROFINS SCIENTIFIC | 529900JEHFM47DYY3S57 | 19/11/2025 | FR0014000MR3 | 20 000 | 57.8022 | XPAR |
EUROFINS SCIENTIFIC | 529900JEHFM47DYY3S57 | 20/11/2025 | FR0014000MR3 | 20 000 | 57.7432 | XPAR |
EUROFINS SCIENTIFIC | 529900JEHFM47DYY3S57 | 21/11/2025 | FR0014000MR3 | 25 000 | 57.6295 | XPAR |
TOTAL | 105 000 | 57.9165 |
Transaction details
In accordance with Article 5(1)(b) of Regulation (EU) N° 596/2014 (the Market Abuse Regulation) a full breakdown of the individual trades are disclosed on Eurofins Scientific SE website: https://www.eurofins.com/investors/share-buy-back-programmes
View source version on businesswire.com: https://www.businesswire.com/news/home/20251124640913/en/
Contacts
Eurofins